HUTCHMED China Ltd (HCM) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.029x

Based on the latest financial reports, HUTCHMED China Ltd (HCM) has a cash flow conversion efficiency ratio of -0.029x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-36.45 Million ≈ $-4.43K USD) by net assets (GBX1.24 Billion ≈ $151.11K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HCM defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

HUTCHMED China Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how HUTCHMED China Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HUTCHMED China Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HUTCHMED China Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ping An Biomedical Co., Ltd. NASDAQ:PASW	N/A
Quickfee Ltd AU:QFE	-0.564x
Kamdhenu Ventures Limited NSE:KAMOPAINTS	0.003x
VentriPoint Diagnostics Ltd V:VPT	0.021x
IXUP Ltd AU:IXU	-0.742x
China Times Publishing Co TWO:8923	0.071x
Cassius Mining Ltd AU:CMD	-0.253x
Dyandra Media International PT JK:DYAN	-0.037x

Annual Cash Flow Conversion Efficiency for HUTCHMED China Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of HUTCHMED China Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see HCM market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX771.85 Million ≈ $93.91K	GBX497.00K ≈ $60.47	0.001x	-99.78%
2023-12-31	GBX743.39 Million ≈ $90.45K	GBX219.26 Million ≈ $26.68K	0.295x	+169.93%
2022-12-31	GBX636.87 Million ≈ $77.49K	GBX-268.60 Million ≈ $-32.68K	-0.422x	-114.67%
2021-12-31	GBX1.04 Billion ≈ $126.48K	GBX-204.22 Million ≈ $-24.85K	-0.196x	-64.27%
2020-12-31	GBX518.95 Million ≈ $63.14K	GBX-62.07 Million ≈ $-7.55K	-0.120x	+53.75%
2019-12-31	GBX312.90 Million ≈ $38.07K	GBX-80.91 Million ≈ $-9.84K	-0.259x	-224.54%
2018-12-31	GBX412.25 Million ≈ $50.16K	GBX-32.85 Million ≈ $-4.00K	-0.080x	-332.07%
2017-12-31	GBX484.97 Million ≈ $59.01K	GBX-8.94 Million ≈ $-1.09K	-0.018x	+60.68%
2016-12-31	GBX204.06 Million ≈ $24.83K	GBX-9.57 Million ≈ $-1.16K	-0.047x	+48.90%
2015-12-31	GBX102.28 Million ≈ $12.44K	GBX-9.38 Million ≈ $-1.14K	-0.092x	-182.34%
2014-12-31	GBX119.88 Million ≈ $14.59K	GBX13.36 Million ≈ $1.63K	0.111x	+132.36%
2013-12-31	GBX104.84 Million ≈ $12.76K	GBX5.03 Million ≈ $611.76	0.048x	-74.38%
2012-12-31	GBX83.65 Million ≈ $10.18K	GBX15.66 Million ≈ $1.91K	0.187x	+178.34%
2011-12-31	GBX77.33 Million ≈ $9.41K	GBX5.20 Million ≈ $632.88	0.067x	+123.36%
2010-12-31	GBX68.81 Million ≈ $8.37K	GBX-19.82 Million ≈ $-2.41K	-0.288x	-286.53%
2009-12-31	GBX75.30 Million ≈ $9.16K	GBX11.63 Million ≈ $1.41K	0.154x	+191.37%
2008-12-31	GBX84.43 Million ≈ $10.27K	GBX-14.27 Million ≈ $-1.74K	-0.169x	-91.86%
2007-12-31	GBX97.61 Million ≈ $11.88K	GBX-8.60 Million ≈ $-1.05K	-0.088x	-166.27%
2006-12-31	GBX109.98 Million ≈ $13.38K	GBX-3.64 Million ≈ $-442.64	-0.033x	-106.81%
2005-12-31	GBX-28.01 Million ≈ $-3.41K	GBX-13.60 Million ≈ $-1.65K	0.485x	--

About HUTCHMED China Ltd

LSE:HCM UK Drug Manufacturers - Specialty & Generic

Market Cap

$18.30 Million

GBX150.38 Billion GBX

Market Cap Rank

#25389 Global

#266 in UK

Share Price

GBX175.00

Change (1 day)

+0.57%

52-Week Range

GBX172.00 - GBX286.00

All Time High

GBX624.00